| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bioequivalence study of single-dose lenalidomide capsule vs. Revlimid® capsule in healthy Chinese males
|
Wang, Jin
|
|
2018
|
82 |
1 |
p. 159-164
|
artikel
|
| 2 |
Comparison of tumor size assessments in tumor growth inhibition-overall survival models with second-line colorectal cancer data from the VELOUR study
|
Claret, Laurent
|
|
2018
|
82 |
1 |
p. 49-54
|
artikel
|
| 3 |
Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR–TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations
|
Imai, Hisao
|
|
2018
|
82 |
1 |
p. 119-127
|
artikel
|
| 4 |
Exposure–response analysis of alectinib in crizotinib-resistant ALK-positive non-small cell lung cancer
|
Morcos, Peter N.
|
|
2018
|
82 |
1 |
p. 129-138
|
artikel
|
| 5 |
Exposure–response relationship for ramucirumab from the randomized, double-blind, phase 3 REVEL trial (docetaxel versus docetaxel plus ramucirumab) in second-line treatment of metastatic non-small cell lung cancer
|
Smit, Egbert F.
|
|
2018
|
82 |
1 |
p. 77-86
|
artikel
|
| 6 |
Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy
|
Litviakov, Nikolai
|
|
2018
|
82 |
1 |
p. 99-109
|
artikel
|
| 7 |
Interactions of lean soft-tissue and chemotherapy toxicities in patients receiving anti-cancer treatments
|
Hopkins, Jessica J.
|
|
2018
|
82 |
1 |
p. 1-29
|
artikel
|
| 8 |
LAPTM4B gene copy number gain is associated with inferior response to anthracycline-based chemotherapy in hormone receptor negative breast carcinomas
|
Rusz, Orsolya
|
|
2018
|
82 |
1 |
p. 139-147
|
artikel
|
| 9 |
Phase II trial of induction chemotherapy of pemetrexed plus split-dose cisplatin followed by pemetrexed maintenance for untreated non-squamous non-small-cell lung cancer
|
Koba, Taro
|
|
2018
|
82 |
1 |
p. 111-117
|
artikel
|
| 10 |
Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity
|
Anon, Benjamin
|
|
2018
|
82 |
1 |
p. 149-157
|
artikel
|
| 11 |
Randomized phase 2 study of gemcitabine and cisplatin with or without vitamin supplementation in patients with advanced esophagogastric cancer
|
van Zweeden, A. A.
|
|
2018
|
82 |
1 |
p. 39-48
|
artikel
|
| 12 |
Reduced dose pegfilgrastim is associated with less bone pain without increased neutropenia: a retrospective study
|
Lower, Elyse E.
|
|
2018
|
82 |
1 |
p. 165-170
|
artikel
|
| 13 |
Role of toll-like receptor 4 (TLR4)-mediated interleukin-6 (IL-6) production in chemotherapy-induced mucositis
|
Khan, S.
|
|
2018
|
82 |
1 |
p. 31-37
|
artikel
|
| 14 |
Sunitinib does not acutely alter left ventricular systolic function, but induces diastolic dysfunction
|
Wada, Takeshi
|
|
2018
|
82 |
1 |
p. 65-75
|
artikel
|
| 15 |
Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer
|
Lee, Jessica
|
|
2018
|
82 |
1 |
p. 55-63
|
artikel
|
| 16 |
UGT1A polymorphisms associated with worse outcome in colorectal cancer patients treated with irinotecan-based chemotherapy
|
Yu, Qianqian
|
|
2018
|
82 |
1 |
p. 87-98
|
artikel
|
Tijdschrift beschrijving